Rheinmetall's Order Book Is Full — Its Cash Register Is Not

Rheinmetall's capital markets day on 27 November now carries more weight than any guidance update. After a second cut to its 2026 outlook in three months, the defence group must show investors a credible path from signed contracts to cash in the bank.

The scale of the challenge became clear on Wednesday when the stock lost 12% following the downgrade. The trigger was a warning that the Boxer project Arminius and lot acceptances for artillery ammunition are likely to be delayed, pushing associated advance payments and revenue contributions into 2027. Revenue shifts in the weapons and ammunition business added to the pressure.

Nine-Month Growth Masks a Cash Problem

For the first nine months of 2026, Rheinmetall reported revenue of EUR 8.4 billion, up 38% year on year. Operating profit climbed 69% to EUR 1,339 million, producing an operating margin of 16.0%. On the surface, the growth story remains intact.

The cash picture tells a different story. Operating free cash flow in the third quarter of 2026 came in at minus EUR 82 million. Management still expects a positive figure for the full year, but has abandoned its previous target of a cash conversion rate above 40%.

That combination warrants caution on earnings quality while cash generation lags operating growth. Rheinmetall must manage the timing gap between production, acceptance and payment. For shareholders, the key question is how reliable the expected inflows are — and what room for manoeuvre exists if further delays materialise.

Arminius Becomes the Litmus Test

Reuters reported that Rheinmetall had counted on an advance payment of 30%, or more than EUR 3 billion, from the Arminius project. The contract award is now not expected until 2027. A substantial liquidity component therefore hinges on a delayed major order.

That makes Arminius the proving ground for the financial plan. A large expected down payment strengthens the outlook — provided the contract is actually signed and the money arrives as planned. While the award remains outstanding, a plan with clearly explained alternatives deserves more confidence than a precise forecast.

Later acceptances of artillery ammunition shift both revenue and cash flow. At the same time, Rheinmetall still expects capital expenditure of more than EUR 1 billion for 2026. The financial demands remain high while important revenue has become less certain in timing.

A EUR 78 Billion Backlog Needs a Schedule

The underlying demand base supports Rheinmetall, provided the group can work through its orders on a predictable basis. Judging the stock therefore requires more attention to the feasibility of the backlog than to its sheer size. Delivery capability, acceptance dates and contractual payment flows are what matter.

At the end of September 2026, the order backlog stood at EUR 78 billion. According to the quarterly conference call, 70% of that consisted of firm orders. That provides a foundation for further business, but its financial value only crystallises through actual execution.

At the capital markets day, Rheinmetall should explain exactly that translation: which orders contribute to revenue in the near term, which require further investment, and when cash actually flows. Such a presentation would strengthen the growth narrative — if it treats risks as concretely as opportunities.

Guidance Cut and Analyst Pushback

The downgrade published on Wednesday targets revenue of around EUR 13.2 billion for 2026, down from a previous range of EUR 13.7–14.2 billion. The operating margin is now expected at around 18.5%, versus roughly 19% before.

JPMorgan responded on Thursday by cutting its price target to EUR 1,150 from EUR 1,350, keeping a "Neutral" rating, as dpa-AFX reported. Analyst David Perry pointed to the company's repeated profit warnings. He also maintained his caution about possible further negative share price catalysts, focusing on the capital markets day on 27 November, which JPMorgan flagged as a potential occasion for another review of longer-term corporate targets. Rheinmetall has announced the same date for its event.

The repeated adjustments raise the bar for the next set of plans. JPMorgan counts five revenue or profit warnings within eleven months. Analysts at mwb Research view the cash conversion as disappointing and consider the beat on operating profit expectations to be of little quality. That criticism strikes at the core while profit growth and cash generation diverge.

Rheinmetall could rebuild trust by setting its assumptions more conservatively and disclosing their dependencies. Statements that hold up even if contract awards slip would be particularly valuable.

The bull case rests on the large order backlog — provided it turns into reliably paid business. Against a rapid re-rating stands the dependence on delayed awards and acceptances, as long as their financial consequences remain hard to calculate. The capital markets day should above all demonstrate a robust route from order to cash. That is the yardstick by which the next round of growth promises should be measured.